D.E. Shaw & Co
TDAC

D.E. Shaw & Co’s Translational Development Acquisition Corp TDAC Stock Holding History

D.E. Shaw & Co’s Portfolio TDAC Stock Details TDAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-346,900
Closed -$3.66M – 5322
2026
Q1 		$3.66M Hold
346,900
– – ﹤0.01% 2413
2025
Q4 		$3.64M Hold
346,900
– – ﹤0.01% 2578
2025
Q3 		$3.59M Hold
346,900
– – ﹤0.01% 2506
2025
Q2 		$3.57M Buy
+346,900
New +$3.52M ﹤0.01% 2286

Other funds holding TDAC

LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

D.E. Shaw & Co's TDAC Position: Q2 2026 in Review

D.E. Shaw & Co sold out of Translational Development Acquisition Corp (TDAC) in Q2 2026, closing a stake of 346,900 shares — an estimated $3.66M sold.

D.E. Shaw & Co first reported a position in TDAC in Q2 2025 and held it in 4 quarters. The position peaked at $3.66M in Q1 2026. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • D.E. Shaw & Co reported no remaining Translational Development Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • D.E. Shaw & Co sold 346,900 Translational Development Acquisition Corp shares in Q2 2026, an estimated $3.66M.
  • D.E. Shaw & Co first reported a position in Translational Development Acquisition Corp in Q2 2025 and held it in 4 quarters.
  • D.E. Shaw & Co's Translational Development Acquisition Corp position peaked at $3.66M in Q1 2026.
  • 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.